Dietary Apigenin Relieves Body Weight and Glycolipid Metabolic Disturbance via Pro‐Browning of White Adipose Mediated by Autophagy Inhibition
Molecular Nutrition & Food Research · 2023-09 · 67 (18)
DOI: 10.1002/mnfr.202200763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 12.07.2023. Verfasst von Shaofeng Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Provincial Key Laboratory of Basic Pharmacology, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China. Hauptthemen laut MEDLINE: Apigenin, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Scope Apigenin (AP) has many pharmacological activities, including anti‐inflammation, hyperlipidemia‐lowering, and so on. Previous studies show that AP can reduce lipid accumulation in adipocytes in vitro. However, it remains unclear whether and how AP can promote fat‐browning. Therefore, mouse obesity model and preadipocyte induction model in vitro are used to investigate the effects of AP on glycolipid metabolism, browning and autophagy as well as the possible mechanisms. Methods and results The obese mice are intragastrically administrated with AP (0.1 mg g −1 d −1 ) for 4 weeks; meanwhile, the differentiating preadipocytes are respectively treated with the indicated concentrations of AP for 48 h. Metabolic phenotype, lipid accumulation, and fat‐browning are respectively evaluated by morphological, functional, and specific markers analysis. The results show that AP treatment alleviates the body weight, glycolipid metabolic disorder, and insulin resistance in the obese mice , which is contributed to the pro‐browning effects of AP in vivo and in vitro. Moreover, the study finds that the pro‐browning effect of AP is accomplished through autophagy inhibition mediated by the activation of PI3K‐Akt‐mTOR pathway. Conclusions The findings highlight that autophagy inhibition promotes the browning of white adipocytes and suggest that AP would prevent and treat obesity and the associated metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Provincial Key Laboratory of Basic Pharmacology, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.
- Department of Pharmacology, School of Pharmacy, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.
- The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.
- Nanchang Joint Programme, Queen Mary University of London, Nanchang, Jiangxi, 330006, P. R. China.
- 302 Clinical Medical School, Peking University, Beijing, 100039, P. R. China.
ORCID-Profile: Qiren Huang
Zitieren
APA
Xiong, S., Yu, S., Wang, K., Xiong, X., Xia, M., Zeng, G., & Huang, Q. (2023). Dietary Apigenin Relieves Body Weight and Glycolipid Metabolic Disturbance via Pro‐Browning of White Adipose Mediated by Autophagy Inhibition. Molecular Nutrition & Food Research, 67(18). https://doi.org/10.1002/mnfr.202200763
Vancouver
Xiong S, Yu S, Wang K, Xiong X, Xia M, Zeng G, et al. Dietary Apigenin Relieves Body Weight and Glycolipid Metabolic Disturbance via Pro‐Browning of White Adipose Mediated by Autophagy Inhibition. Molecular Nutrition & Food Research. 2023;67(18). doi:10.1002/mnfr.202200763
BibTeX
@article{Xiong2023,
author = {Xiong, Shaofeng and Yu, Shumin and Wang, Kun and Xiong, Xiaowei and Xia, Min and Zeng, Guohua and Huang, Qiren},
title = {Dietary Apigenin Relieves Body Weight and Glycolipid Metabolic Disturbance via Pro‐Browning of White Adipose Mediated by Autophagy Inhibition},
journal = {Molecular Nutrition & Food Research},
year = {2023},
volume = {67},
number = {18},
doi = {10.1002/mnfr.202200763}
}
EUVIMED